2150. <i>In Vitro</i> Activity of Cefepime-Taniborbactam and Comparators Against Genotypically Characterized Carbapenem-Resistant Enterobacterales (CRE) and Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> (CRPA) from the United States, 2018-2021
Open forum infectious diseases